Anilkumar J.SHINDE, Harinath N.MORE, Rahul S.DALAVI

Designanddevelopmentofmeltsolidificationof meloxicam for enhancement of solubility and dissolution

The objective of the present study wasto prepare an amorphous system of BCS Class2 drug meloxicam(MLX)to improve its solubility and dissolution byusingthe melt solidification techniques. About 40% of new chemical entities do not reach to market due to its poor aqueous solubility. Melt solidification technique is an important process to control the transition from liquid into solid phase to obtain product in an amorphous form. During the process of heating, some solid gets melted and if quench cooled, instead of crystallizing gets converted to amorphous solid form appearing as that of glass,whichimprovedissolution and bioavailabilityof drugs.Physical mixtures of MLX were prepared by melt solidification technique using polymer(soluplus). The solubility and dissolution studies for the meloxicam and batches were conducted in a phosphate buffer (pH 6.8). The fourier transforminfrared(FTIR)spectrophotometry,X-raydiffractionmicroscopy(XDM) andDifferentialscanning calorimetry(DSC) studies were conducted to evaluated pure drug and optimized batch(MS7). Saturation solubility and % drug release showed the improvesolubility and dissolution, resultssuggest that optimized batch (MS7)containing drug and polymer in proportion of 1:4 (MLX:soluplus) was a successful enhancing the solubility and dissolution of MLX. The % crystallinity of MLXin amorphous sample was 18.60%,which indicates significant decrease in crystallinity of MLXin an amorphous system. The best fit model of optimized batch (MS7) waszero order model, showing the %drug release 96.83% and R20.9904. The present investigation, successfully enhancement solubility and dissolution of MLXbyusingmelt solidification technique.

PDF

___

[1]Reppas C, Kalantzi L.Biowaiver monographs for immediate release solid oraldosage forms: Acetaminophen.JPharmSci.2006;95(1):4-14.[CrossRef]
[2]Alleso M, Chieng N, Rehder S, Rantanen J, Rades T, Aaltonen J. Enhanceddissolutionrate and synchronizedReleaseof drugs in binary systems throughformulation: Amorphous naproxen–cimetidinemixtures prepared by mechanicalactivation. JControl Rel.2009;136:45–53.[CrossRef]
[3]Hancock B,Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. JPharmSci.1997;86:1–12.[Cross Ref]
[4]Kaushal A, Bansal K. Thermodynamic behavior of glassy state of structurally related compounds. EurJ PharmBiopharm.2008;69:1067–1076.[CrossRef]
[5]Bodmeier R,Wang J,Bhagwatwar H. Process and formulation variables in the preparation of wax microparticles by melt dispersion technique for water insoluble drugs.J Microcapsulation.1992;9:89-98.[CrossRef]
[6]Ambike A, Mahadik K, Paradkar A. Stability study of amorphous valdecoxib. Int JPharm.2004;282:151-162.[CrossRef]
[7]Shinde R,Shelake M, Shetty S, Chavan Patil A, Pore Y, Late S. Enhanced solubility and dissolution rateof lamotrigine by inclusion complexation and solid dispersion technique.JPharmPharmacol.2008;60(9):1121-1129.[CrossRef]
[8]Baird J. Evaluation of amorphous solid dispersion properties using thermalanalysis techniques.AdvDrugDeli Rev.2012;64:396-421.[CrossRef]
[9]Sanghvi R, Evans D, Yalkowsky S. Stacking complexation bynicotinamide:A useful way of enhancing drug solubility.Int JPharm.2007;336(1):35-41.[CrossRef]
[10]Carstensen J.Advanced pharmaceutical solids.Marcel Dekker, New York,2001;117-227.
[11]Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Preparation andcharacterization of nanocrystals for solubility and dissolution rate enhancement ofnifedipine.Int J Pharm. 2005;299(1-2):167-177.[CrossRef]
[12]Balania P, Wonga S. Influence of polymer content on stabilizing milled amorphoussalbutamol sulphate. IntJPharm.2010;391:125–136.[CrossRef]
[13]Amina M,MyasarM,khayrallah A. Preparation and evaluation of meloxicam solid dispersion by solventevaporation method. Int Res J Pharm.2014;5:838-845.
[14]Bhende S, Jadhav N. Moringa coagulant as a stabilizer for amorphous solidAAPS PharmSciTech.2012;13(2):400-410.[CrossRef]
[15]Amidon G, Lennernas H, Shah V,Crison J. A theoretical base for abiopharmaceuticaldrugclassification: the correlation of in vitrodrug productdissolution and in vivo bioavailability.Pharm Res.1995;12(3):413-420.[CrossRef]
[16]Branham M, Moyo T, Govender T. Preparation and solid-state characterization of ballmilled saquinavir mesylate for solubility enhancement.Eur JPharma and Biopharm.2012;80:194-202.[CrossRef]
[17]Chieng N, Aaltonen J, Saville D, Rades T. Physicalcharacterization and stability ofamorphous indomethacin and ranitidine hydrochloride binary systems prepared bymechanical activation. EurJ Pharm Biopharm.2009;71:47–54.[CrossRef]
[18]Hancock B, Zografi G. Characteristics and significance of the amorphous state inpharmaceutical systems.PharmSci.1997;86:1–12.[CrossRef]
[19]Hassan M, Najib N, Suleiman M. Characterization of glibenclamide glassy state. IntJ Pharm.1991;67(2):131–137. [CrossRef]
[20]Hilden L, Morris K. Physics of amorphous solids. JPharm Sci.2004;93:3–12.[CrossRef]
[21]Jacob S, Nair A, Patil N, Panda P. Solid state crystallinity, amorphous state, and itimplications in thepharmaceutical process. IntJ Pharm Sci Res.2011;2(3):472-482.
[22]Karmwar P, Graeser K, Gordon K, Strachan C, Rades T. Investigation of propertiesand recrystallizationbehaviorof amorphous indomethacin samples prepared bydifferent methods. Int J Pharm.2011;417(1–2):94–100.[CrossRef]
[23]Jadhav N,Gaikwad V,Nair K. Glass transition temperature: Basics and application in pharmaceutical sector.Asian J Pharm.2010;3:83-88.
[24]Kulkarni P,Dixit,Kumar S,Johri A.Preparation and evaluation of ketoprofen beads by melt solidification technique. Pelagia Res Lib.2010;1(2):31-43.
[25]Paradkar A,MaheshwariM,Ketkar A. Chouhan, B. Preparation and evaluation of ketoprofen beads by melt solidification technique. Int J Pharm.2003;33-42.
[26]Pokharkar V, Mandpe L,Padamwar M, Ambike A, Mahadik K, Paradkar A. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Techno.2006;167:20–25.
[27]ParadkarA, KambleR, KadamS. Melt solidification technique: Incorporation of higher wax content in ibuprofen beads.AAPS Pharmtech Sci.2004;4:325-329.[CrossRef]